The renowned 4th Dermatology Drug Development Summit Europe returns as the definitive industry-led conference for all administration routes, for chemistry and non-clinical researchers, through to clinical drug developers and strategic decision makers. 

Bringing you fresh content covering Hidradenitis Suppurativa, Pachyonychia Congenita, Keratodermas and Neurofibromas as well as the latest advances in Atopic Dermatitis.

Equip your chemists with knowledge of chemical modifications to promote stability and mitigate the risk of off-target effects reducing toxicity. Debate optimal dosing strategies topical vs oral vs intravenous. Evaluate a range of current and future drug delivery methods and discuss important considerations when treating hyperkeratotic skin 

Whatever your role in the dermatology field, this summit is designed to equip you with the tools to tackle the next dermatology opportunity, progressing existing treatments and developing successful therapies for rarer dermatological diseases.

Read on dermatology-drugdevelopment-europe.com

Continue reading at dermatology-drugdevelopment-europe.com

Dermatology

Facebook Share

Twitter Share

Linkedin Share

Email Share